Literature DB >> 9101361

Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss.

Z H Han1, S Palnitkar, D S Rao, D Nelson, A M Parfitt.   

Abstract

We measured histologic indices of bone remodeling and turnover separately on the cancellous, endocortical, and intracortical subdivisions of the endosteal envelope, and on the combined total surface, in transiliac bone biopsies obtained after double tetracycline labeling in 142 healthy women, aged 20-74 years, 34 black and 108 white, 61 premenopausal and 81 postmenopausal. The data were analyzed by two-way analysis of variance of the four groups defined by age/menopause and ethnicity and by linear regression of the major variables on age. None of the interaction terms was significant and none of the regression slopes on age differed between blacks and whites, indicating that, as for the previously reported structural indices, the effects of ethnicity and of age/menopause are independent. Accordingly, the data were also analyzed separately for the effect of ethnicity (pre- and postmenopausal combined) and age/menopause (blacks and whites combined). The analyses led to the following conclusions. (1) The geometric mean bone formation rate on the combined total surface was 25% lower in blacks than in whites; other histologic differences between ethnic groups were inconsistent between surfaces. (2) Serum osteocalcin (OC) but not bone-specific alkaline phosphatase (BSAP) was lower by about 15% in blacks than in whites. (3) The lower bone turnover in blacks is most likely in the directed rather than in the stochastic component because of a higher bone mass and consequent reduced susceptibility to fatigue damage. (4) All Class 1 bone formation variables and the three resorption indices were significantly higher in the postmenopausal compared with the premenopausal subjects, reflecting a 33% increase in activation frequency. (5) BSAP, but not OC, was increased relatively more (66%) than the bone formation rate (BFR). Consequently, BSAP is more sensitive to the effects of menopause than OC, but OC is more sensitive to the effects of ethnicity than BSAP. (6) There were highly significant differences between the three subdivisions of the endosteal envelope for every non-cell-related variable. All Class 1 formation variables were highest on the endocortical surface, but the magnitude and pattern of the differences otherwise was inconsistent between variables. The contributions of the different subdivisions to the total bone formation rate were cancellous 54%, endocortical 13%, and intracortical 33%. (7) The previously reported changes in bone surface location, together with the presently reported changes in activation frequency and wall thickness indicated that there was no significant effect of age/menopause on erosion depth on the cancellous and intracortical surfaces but a large increase in erosion depth on the endocortical surface. (8) The increase in bone turnover that results from hormonal changes is most likely in the stochastic rather than in the directed component because it serves no purpose but has harmful effects on skeletal integrity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101361     DOI: 10.1359/jbmr.1997.12.4.498

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  44 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Preservation of femoral bone thickness in middle age predicts survival in genetically heterogeneous mice.

Authors:  Richard A Miller; Jaclynn Kreider; Andrzej Galecki; Steven A Goldstein
Journal:  Aging Cell       Date:  2011-03-22       Impact factor: 9.304

3.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

4.  Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

Authors:  Fettah Fevzi Ersoy; Stauros Ploumis Passadakis; Paul Tam; Evaggelos Dimitros Memmos; Pericles Konstantinos Katopodis; Cetin Ozener; Fehmi Akçiçek; Taner Camsari; Kenan Ateş; Rezzan Ataman; John George Vlachojannis; Athanasios Nicholas Dombros; Cengiz Utaş; Tekin Akpolat; Semra Bozfakioğlu; George Wu; Ibrahim Karayaylali; Turgay Arinsoy; Panagiotis Charalampos Stathakis; Mahmut Yavuz; John Dimitrios Tsakiris; Chrysostomos Athanasios Dimitriades; Mehmet Emin Yilmaz; Meral Gültekin; Binnur Karayalçin; Mehmet Yardimsever; Dimitrios George Oreopoulos
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 5.  Sex and ethnic differences in bone architecture.

Authors:  Dorothy A Nelson; Mary S Megyesi
Journal:  Curr Osteoporos Rep       Date:  2004-06       Impact factor: 5.096

Review 6.  The periosteum--a surface for all seasons.

Authors:  E Seeman
Journal:  Osteoporos Int       Date:  2007-02       Impact factor: 4.507

7.  Brazilian normal static bone histomorphometry: effects of age, sex, and race.

Authors:  Luciene M Dos Reis; João R Batalha; Daniel R Muñoz; Aurélio Borelli; Pedro H S Correa; Aluizio B Carvalho; Vanda Jorgetti
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

8.  The remodeling transient and the calcium economy.

Authors:  J F Aloia; S Arunabh-Talwar; S Pollack; J K Yeh
Journal:  Osteoporos Int       Date:  2008-01-26       Impact factor: 4.507

Review 9.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

10.  Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?

Authors:  Oliver Ristow; Carlos Gerngroß; Markus Schwaiger; Bettina Hohlweg-Majert; Melanie Ristow; Steffen Koerdt; Roswitha Schuster; Sven Otto; Christoph Pautke
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.